Category: pharma

New CDC Warning: Invasive Strep A Infections Among Children Rising

There have already been two reported deaths among those with invasive Group A Strep. Here are the precautions that you can take.

New FDA Update Reaffirms Plan B ‘Morning-After Pill’ Is Not Abortion Drug

This came after nine states have enacted legislation to restrict access to this emergency contraceptive.

‘The Grinch’ TikTok Trend Shows Parents Scaring Kids Witless, Here Are The Issues

You may have noticed the TikTok videos of parents having a frighteningly good time seeing their kids shriek in horror when “The Grinch” steals their Holiday presents.

For Festivus, Here’s The Airing Of 10 Grievances From 2022

Once again it’s time to celebrate Festivus, that holiday touted by the character Frank Costanza on the TV show Seinfeld.

Is Monty Python ‘Silly Walk’ Good Exercise? Here’s What A Study Showed

Doing the John Cleese “Silly Walk” just 11 minutes a day could get you past the 75 minutes of vigorous physical activity per week threshold that the Centers of Disease Control and Prevention (CDC) recommends.

Class I Recall Of Chicken Products Sold At Walmart In 28 States

Mountain View Packaging, LLC, is recalling around 6,013 pounds of their “Innovasian Crispy Chicken with Almonds Entrée” for a shellfish reason.

Rite Aid May Close Even More Stores In 2023

Rite Aid, which has already been closing unprofitable stores for the last year, may close even more, executives disclosed Wednesday.

Rite Aid Loss Hits $67 Million As Covid Vaccination And Testing

Rite Aid reported a quarterly loss of more than $67 million due in part to “a reduction in COVID vaccine and testing revenue.”

Amazon Could Fuel Doctor Buyouts In 2023 If One Medical Deal Goes Through

The already hot market of buying physician practices is about to get even hotter should Amazon’s proposed acquisition of One Medical win regulatory approval.

The Case For Greater Focus On Innovation In Medicare Advantage

The Centers for Medicare and Medicaid Innovation should amplify its focus on Medicare Advantage to address the popular program’s flaws.